The use of i.v. acetylcysteine
also significantly increased
transplant-free survival rates (43%
versus 22%, p = 0.005) and decreased
the length of hospitalization (19 days
versus 25 days, p = 0.05). Similar
findings were seen with oral acetylcysteine
use for NAI-ALF